An evaluation of denileukin diftitox for the treatment of relapsed or refractory cutaneous T-cell lymphoma
{{output}}
Introduction: Denileukin difitox (DD), a recombinant cytotoxic fusion protein composed of full-length human interleukin-2 (IL-2) conjugated to diphtheria toxin's A and B subunits, has shown activity in patients with relapsed and... ...
